David J. Caponera
Corporate Officer/Principal presso DICERNA PHARMACEUTICALS, INC.
Posizioni attive di David J. Caponera
Società | Posizione | Inizio | Fine |
---|---|---|---|
DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13/06/2019 | - |
Storia della carriera di David J. Caponera
Precedenti posizioni note di David J. Caponera
Società | Posizione | Inizio | Fine |
---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2014 | 01/07/2018 |
Formazione di David J. Caponera
Cornell University | Undergraduate Degree |
Duke University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- David J. Caponera
- Esperienza